Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05226260 · ClinicalTrials.gov registry record · NA
Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care
A NA study of Abscess and Cellulitis, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,634
- Enrollment target
- 1
- Study location
NCT05226260: Completed NA study of Abscess and Cellulitis, sponsored by Nationwide Children's Hospital.
NCT05226260 is a NA study of Abscess and Cellulitis that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 1,634 participants, above the 264-participant average among 13 other Abscess trials with a reported enrollment target (519% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05226260, a NA study of Abscess and Cellulitis, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,634 participants
- Enrollment target
- 1
- Study location
Study Summary
Study the efficacy of a package of behavioral economics strategies (versus an education-only control condition) in altering clinician behavior regarding antibiotic prescription duration for skin and soft tissue infection (SSTI).
Primary Outcome
Rates of long and short antibiotics will be analyzed on the clinic and provider level for both intervention and control groups
Conditions Studied
Interventions
- BEHAVIORAL Default Duration order Panel
Study Locations (1)
Ohio
- Nationwide Children's Hospital Primary Care Clinics - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,634 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2025-01-20 |
| Phase | NA |
What the finished NCT05226260 record still lists
NCT05226260 is an interventional study that assigns participants to a tested intervention. Its 1,634 participants enrollment target places it among the larger protocols in the corpus, above the 264-participant average among 13 other Abscess trials with a reported enrollment target (519% higher).
The record links to 7 conditions, with Abscess appearing as the primary indexed condition, and to 1 intervention - of which Default Duration order Panel is the first listed.
NCT05226260 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05226260 about?
NCT05226260 is a clinical study titled "Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care". Study the efficacy of a package of behavioral economics strategies (versus an education-only control condition) in altering clinician behavior regarding antibiotic prescription duration for skin and soft tissue infection (SSTI).
What is the current status of trial NCT05226260?
This trial is currently completed. It is a NA study. The enrollment target is 1,634 participants. The study started on 2021-11-01. Estimated completion is 2025-01-20.
What conditions does trial NCT05226260 study?
This clinical trial studies the following conditions: Abscess, Cellulitis, Behavioral Economics, Impetigo, Skin Infection.
What interventions are being tested in trial NCT05226260?
The interventions under investigation include: Default Duration order Panel (BEHAVIORAL).
Who is sponsoring clinical trial NCT05226260?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05226260 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abscess
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05226260's enrollment target sits among peer trials
1,634 1st of 13 higher than 13 of 13 other Abscess trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abscess trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults
COMPLETED · NA
-
Evaluation of 3 Versus 10 Days of Antibiotics in Skin Abscesses After Surgical Drainage
COMPLETED · NA
-
Ketamine as a Supplement to Local Anesthesia for Minor Procedures
RECRUITING · Phase 4
-
Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children
COMPLETED · Phase 3
-
Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage
COMPLETED · Phase 2
-
Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- NCT07046260 · 1,650 participants
Prospective Study to Assess a Diagnostic Aid for Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI